CMA
61
5
TGT
22
2
AN
58
4
NWL
53
3
NKE
36
6
EQT
57
-2
EL
25
4
IR
66
3
DHI
48
4
PSA
58
2
LNC
39
3
HD
57
2
WM
79
3
ADBE
49
3
MSFT
50
3
VMC
57
4
A
43
2
HSIC
56
5
PSX
47
2
STI
14
-17
CMA
61
5
TGT
22
2
AN
58
4
NWL
53
3
NKE
36
6
EQT
57
-2
EL
25
4
IR
66
3
DHI
48
4
PSA
58
2
LNC
39
3
HD
57
2
WM
79
3
ADBE
49
3
MSFT
50
3
VMC
57
4
A
43
2
HSIC
56
5
PSX
47
2
STI
14
-17
Financhill
Back

SPDR® S&P Biotech ETF Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

XBI
SPDR® S&P Biotech ETF

Last Price:
96.20
Seasonality Move:
9.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

SPDR® S&P Biotech ETF Stock Forecast

  • Over the next 52 weeks, SPDR® S&P Biotech ETF has on average historically risen by 11.9% based on the past 18 years of stock performance.
  • SPDR® S&P Biotech ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%
  • Is SPDR® S&P Biotech ETF Stock Undervalued?
    The current SPDR® S&P Biotech ETF [XBI] share price is $96.24. The Score for XBI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • XBI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will SPDR® S&P Biotech ETF Stock Go Up Next Year?

  • Over the next 52 weeks, SPDR® S&P Biotech ETF has on average historically risen by 11.9% based on the past 18 years of stock performance.

SPDR® S&P Biotech ETF Stock Rating

Sell
45
SPDR® S&P Biotech ETF (XBI) is a Sell

Is SPDR® S&P Biotech ETF overpriced?

  • SPDR® S&P Biotech ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%

SPDR® S&P Biotech ETF Stock Price History

Is XBI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XBI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
105.47
52-Week Low:
71.99

Prediction Charts

Market Cap:
0
Price in USD:
96.24
Volume:
9.44M
Beta:
0.95

Technical Analysis

SMA50:
98.44
SMA100:
98.37
SMA200:
95.05
52-Wk Change:
32.2%

Stock Predictions

  • Is SPDR® S&P Biotech ETF stock public?
    Yes, SPDR® S&P Biotech ETF is a publicly traded company.
  • What is the SPDR® S&P Biotech ETF stock quote today?
    The SPDR® S&P Biotech ETF stock price is 96.24 USD today.
  • How to buy SPDR® S&P Biotech ETF stock online?
    You can buy SPDR® S&P Biotech ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 98.71 100.62 100.63 98.20
Nov-6 103.28 102.44 103.31 100.75
Nov-7 103.00 103.01 103.89 102.54
Nov-8 102.88 104.18 104.23 102.56
Nov-11 104.84 103.53 105.47 103.35
Nov-12 102.50 100.51 103.17 100.39
Nov-13 101.49 100.01 102.43 100.00
Nov-14 99.77 96.96 100.17 96.87
Nov-15 96.91 91.83 96.91 91.64
Nov-18 92.14 91.96 92.74 91.08
Nov-19 91.24 93.17 93.21 90.67
Nov-20 93.29 94.01 94.17 92.40
Nov-21 94.15 94.30 95.44 92.74
Nov-22 94.78 96.24 96.61 94.16

SPDR® S&P Biotech ETF Earnings

Data Unavailable

SPDR® S&P Biotech ETF Forecast Revenue Growth

Data Unavailable

* SPDR® S&P Biotech ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.